The global prostate cancer minimally invasive surgery market was valued at US$ 3.1 Billion in 2024 and is expected to register a CAGR of 4.1% over the forecast period and reach US$ 4.5 Billion in 2033.
The Europe generic injectables market was valued at US$ 20.4 billion in 2024 and is expected to register a CAGR of 3.8% over the forecast period and reach US$ 28.5 billion in 2033.
The global bioMEMS and microsystem in healthcare market was valued at US$ 5.8 billion in 2024 and is expected to register a CAGR of 12.5% over the forecast period and reach US$ 16.7 billion in 2033.
The global rosuvastatin market was valued at US$ 3.14 Billion in 2024 and is expected to register a CAGR of 4.0% over the forecast period and reach US$ 4.47 Billion in 2033.
The targeted protein degradation market was valued at US$ 589.6 Million in 2024 and is expected to register a CAGR of 15.8% over the forecast period and reach US$ 2,207.7 Million in 2033.
The global hyperphosphatemia treatment market was valued at US$ 13.1 Billion in 2024 and is expected to register a CAGR of 5.0% over the forecast period and reach US$ 20.4 Billion in 2033.
The global handheld marijuana vaporizers market was valued at US$ 6.5 Billion in 2024 and is expected to register a CAGR of 20.1% over the forecast period and reach US$ 33.8 Bn in 2033.
The global accidеnt warning systеms market was valued at US$ 67.2 Billion in 2024 and is expected to register a CAGR of 8.7% over the forecast period and reach US$ 142.4 Billion in 2033.
Recent Comments